全文获取类型
收费全文 | 11313篇 |
免费 | 787篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 345篇 |
儿科学 | 233篇 |
妇产科学 | 177篇 |
基础医学 | 1687篇 |
口腔科学 | 252篇 |
临床医学 | 831篇 |
内科学 | 2115篇 |
皮肤病学 | 220篇 |
神经病学 | 759篇 |
特种医学 | 523篇 |
外国民族医学 | 1篇 |
外科学 | 2199篇 |
综合类 | 84篇 |
一般理论 | 6篇 |
预防医学 | 711篇 |
眼科学 | 733篇 |
药学 | 589篇 |
中国医学 | 6篇 |
肿瘤学 | 668篇 |
出版年
2023年 | 118篇 |
2022年 | 172篇 |
2021年 | 310篇 |
2020年 | 198篇 |
2019年 | 304篇 |
2018年 | 310篇 |
2017年 | 257篇 |
2016年 | 268篇 |
2015年 | 255篇 |
2014年 | 394篇 |
2013年 | 452篇 |
2012年 | 623篇 |
2011年 | 620篇 |
2010年 | 363篇 |
2009年 | 332篇 |
2008年 | 529篇 |
2007年 | 558篇 |
2006年 | 532篇 |
2005年 | 529篇 |
2004年 | 458篇 |
2003年 | 430篇 |
2002年 | 415篇 |
2001年 | 249篇 |
2000年 | 254篇 |
1999年 | 224篇 |
1998年 | 109篇 |
1997年 | 86篇 |
1996年 | 95篇 |
1995年 | 100篇 |
1994年 | 88篇 |
1993年 | 65篇 |
1992年 | 135篇 |
1991年 | 152篇 |
1990年 | 134篇 |
1989年 | 121篇 |
1988年 | 127篇 |
1987年 | 148篇 |
1986年 | 141篇 |
1985年 | 122篇 |
1984年 | 89篇 |
1983年 | 78篇 |
1981年 | 49篇 |
1979年 | 84篇 |
1978年 | 57篇 |
1976年 | 52篇 |
1975年 | 48篇 |
1974年 | 55篇 |
1973年 | 52篇 |
1933年 | 40篇 |
1925年 | 41篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Kragh Thomsen M. Rasmussen M. Fuursted K. 《世界核心医学期刊文摘》2006,2(9):2-22
2000年11月,作者得知从Aarhus大学医院皮肤科患者分离到的金黄色葡萄球菌对苯唑西林出现界线耐药(BORSA)。本文旨在描述其表型和基因型,并评估可能的传播途径以干预和阻止进一步蔓延。菌株由脉冲场凝胶电泳鉴定。几个感染控制方案的缺口显示患者间可直接或间接传播。皮肤屏障缺陷、皮肤病患者金黄色葡萄球菌的高携带率和院内双氯西林的高消耗率可促使传播。改善普通感染控制措施和重新评价院内抗生素政策后,该菌的暴发感染消失。 相似文献
5.
6.
7.
Heung Bae Kim James J Pomposelli Craig W Lillehei Roger L Jenkins Maureen M Jonas Laura E Krawczuk Steven J Fishman 《Liver transplantation》2005,11(11):1389-1394
Extrahepatic portal vein thrombosis (EHPVT) may occur in children or adults and usually comes to clinical attention due to complications of portal hypertension such as variceal hemorrhage. A variety of standard surgical techniques exist to manage these patients, but when these fail surgical options are limited. We describe two novel portosystemic shunts that utilize the gonadal vein as an autologous conduit. Four patients were evaluated for EHPVT with variceal bleeding. None of the patients were candidates for a standard splenorenal shunt due to prior surgical procedures. The first patient underwent a left mesogonadal shunt and the remaining 3 patients underwent a right mesogonadal shunt. Postoperative ultrasound or computed tomography (CT) scan confirmed early patency of the shunt in each patient. There have been no further episodes of variceal hemorrhage with follow-up of 3.5 years in the child who underwent the left mesogonadal shunt, and 17, 19, and 20 months in the patients who underwent the right mesogonadal shunt. Three of the 4 shunts remain patent. One shunt thrombosis occurred in a patient homozygous for the Factor V Leiden mutation despite anticoagulation with coumadin. This is the first report of the successful use of the gonadal vein as an in situ conduit for constructing a portosystemic shunt. In conclusion, the right and left mesogonadal shunts may be useful as salvage operations for patients with EHPVT who have failed standard surgical shunt procedures. 相似文献
8.
Can carotid endarterectomy be justified? No 总被引:1,自引:0,他引:1
S Jonas 《Archives of neurology》1987,44(6):652-654
9.
K Thomsen B J Riis J S Johansen C Christiansen P R?dbro 《Gynecological endocrinology》1987,1(2):169-175
Bone turnover before and after withdrawal of estrogen/gestagen treatment was studied in a randomized trial with 110 healthy female volunteers, who had passed a natural menopause 6 months to 3 years before the start of the study. Urinary excretion of intravenously injected 99m-technetium diphosphonate was measured as an index of bone turnover; plasma bone Gla protein and serum alkaline phosphatase were measured as indices of bone formation; and fasting urinary excretion of hydroxyproline and calcium were measured as estimates of bone resorption. During 2 years of hormone treatment, all variables decreased highly significantly (p less than 0.001) to a constant low level. Three months after withdrawal all variables increased highly significantly (p less than 0.001) towards, but not above, pretreatment and placebo levels. We conclude that withdrawal of estrogen/gestagen replacement therapy in postmenopausal women increases bone turnover, but not in excess of pretreatment values. This indicates that bone loss (after withdrawal) is similar to that seen in the placebo group and that a rebound phenomenon is unlikely. 相似文献
10.
Michael Hermansson Anders Ekedahl Jonas Ranstam Thomas Zilling 《BMC gastroenterology》2009,9(1):25-13